NSW Health's Safety Alert Broadcast System (SABS) has been adapted from the UK's National Health Service Safety Alert Broadcast System. Its aim is to provide a systematic approach to the distribution and management of patient safety information to NSW health services. Each alert specifies action to be taken by health services, the timeframe in which such action must occur, and specific responsibility for the actions.

The Safety Alert Broadcast System Policy Directive PD2013_009 describes how SABS works. Basically, there are three types of notification:

Safety Alert (Red), requiring immediate attention and action.

Safety Notice (Amber), requiring risk assessment at the local level.

Safety Information (Green), ensuring that lessons learned from state-wide, national and international sources are shared actively across the NSW health system.

The SABS register

NumberTypeIssues coveredDate of issue
SN:005/22 Safety Notice (Amber) Infection post cardiopulmonary bypass associated with heater cooler devices - Update23 May 2022
SA:003/22 Safety Alert Red Critical disruption to supply - Non-ionic iodinated contrast media agents17 May 2022
SN:004/22 Safety Notice (Amber) ‘Sterile Theatre Pack’ formulations of lignocaine (lidocaine) with adrenaline (epinephrine) and bupivacaine with adrenaline (epinephrine) injection disruption to supply13 May 2022
SN:003/22 Safety Notice (Amber) Risk of retained intubating stylet fragment in neonates19 April 2022
SN:001/22 Safety Notice (Amber) Avoiding thrombophlebitis with intravenous amiodarone 4 March 2022
SA:002/22 Safety Alert Red Increased risk of presentation of Japanese Encephalitis 28 Feburary 2022
SA:001/22 Safety Alert Red FOOD RECALL Elecare, Similac and Alimentum infant formula 21 Feburary 2022
SI:001/22 Safety Information Green Recognition and prompt treatment of clozapine-induced constipation7 February 2022
SN:026/21 Safety Notice (Amber) Safety risks due to new labelling of intravenous calcium gluconate15 December 2021
SN:024/21 Safety Notice (Amber) Ensuring the safe and appropriate use of casirivimab and imdevimab7 December 2021
SI:010/21 Safety Information Green Electronic Fetal Monitoring (EFM) during water immersion30 November 2021
SI:009/21 Safety Information Green Recirculating air filtration device use in NSW hospitals26 November 2021
SN:022/21 Safety Notice (Amber) Preparation of Pfizer COVID-19 vaccines17 September 2021
SN:021/21 Safety Notice (Amber) Safety risks due to new labelling on the outer carton packaging of intravenous potassium chloride ampoules 10 September 2021
SN:020/21 Safety Notice (Amber) Remdesivir 100mg injection –disruption to supply9 September 2021
SA:002/21 Safety Alert Red Urgent stock preservation of tocilizumab injections for COVID-19 patients required31 August 2021
SN:019/21 Safety Notice (Amber) Flow sensors used in selected GE healthcare / datex-ohmeda anaesthesia machines30 August 2021
SI:004/21 Safety Information Green Povidone-Iodine Solution Use in NSW Hospitals19 August 2021
SN:018/21 Safety Notice (Amber) Myocarditis and pericarditis after mRNA COVID-19 vaccines18 August 2021
SN:017/21 Safety Notice (Amber) Illicit cocaine containing high levels of lidocaine (lignocaine)13 August 2021
SA:001/21 Safety Alert Red Critical disruption to the supply of tocilizumab 9 August 2021
SN:016/21  Safety Notice (Amber) Identification and monitoring of Post-Injection Syndrome Olanzapine Pamoate Long Acting Injection (updated)9 August 2021
SI:007/21 Safety Information Green Safe use of medications with multiple concentrations in Electronic Medication Management (EMM) systems9 July 2021
SN:015/21 Safety Notice (Amber) Philips Sound Abatement Foam on selected sleep and respiratory devices – Product Defect Correction 5 July 2021
SN:014/21 Safety Notice (Amber) 25C-NBOMe toxicity in patients who used powder thought to be MDMA2 July 2021
SI:06/21 Safety Information Green Patient identity checks before administration of blood products21 June 2021
SN:012/21 Safety Notice (Amber) Enoxaparin 20 mg and 40 mg syringes: Disruption to supply1 June 2021
SI:05/21 Safety Information Green Reporting Adverse Events Following Immunisation23 May 2021
SI:003/21 Safety Information Green Paediatric stationary oxygen concentrator set-up - Absence of low flow alarm for flow rates less than 2 litres per minute20 May 2021
SN:010/21 Safety Notice (Amber) Requirements for post-transplant blood-borne virus surveillance of recipients of organs from increased-risk donors18 May 2021
SN:009/21 Safety Notice (Amber) Illicit cocaine containing strong opioids14 May 2021
SN:008/21 Safety Notice (Amber) Medtronic Covidien DAR™ airway products – Deviation in sterilisation processing29 April 2021
SN:005/21 Safety Notice (Amber) HYDROmorphone (Dilaudid®) Oral Liquid 1 mg/mL – Discontinued17 March 2021
SN:003/21 Safety Notice (Amber) Breast implant associated-anaplastic large cell lymphoma (BIA-ALCL) 1 March 2021
SN:002/21 Safety Notice (Amber) Variability in oxygen delivery with bag valve masks15 February 2021
SI:001/21 Safety Information Green Minimising the risks of serious harm while switching antipsychotics20 January 2021
SN:001/21 Safety Notice (Amber) Discontinuation of nifedipine immediate release products (update)18 January 2021
SN:011/20 Safety Notice (Amber) Heroin and cocaine containing fentanyl and acetylfentanyl26 November 2020
SN:009/20 Safety Notice (Amber) Acetylfentanyl and fentanyl in non-opioid illicit drugs16 October 2020
SI:005/20 Safety Information Green Safe use of disposable (single patient use) slings24 September 2020
SN:008/20 Safety Notice (Amber) Illicit supply of counterfeit alprazolam (Updated)9 September 2020
SI:003/20 Safety Information Green The risk of toxicity from topical anaesthetic products22 May 2020
SN:002/20 Safety Notice (Amber) Management of medication for patients with Parkinson disease(Supercedes SN:013/11)11 March 2020
SN:004/20 Safety Notice (Amber) Lantus discontinuation and introduction of new insulin glargine products11 June 2020
SN:001/20 Safety Notice (Amber) Safe provision of sedating medicines on discharge from NSW Health facilities18 February 2020
SA:001/20 Safety Alert Red LIFEPAK® 15 Monitor/Defibrillator defect correction - 202014 January 2020
SI:001/20 Safety Information Green Use of linen in radiological procedures potential artefact13 January 2020
SN:013/19 Safety Notice (Amber) Incompatibility between oxygen cylinders with inbuilt regulators with Air/Oxygen Blenders26 September 2019
SN:012/19 Safety Notice Amber Link adrenaline (epinephrine) 1 in 10,000 prefilled syringe - device failure23 August 2019
SN:007/19 Safety Notice (Amber) High Concentration Insulin Products (Updated) (Supersedes SN:009/17) 24 June 2019
SN:021/18 Safety Notice Amber Discontinuation of nifedipine (twice daily products) and patient safety risks with alternative20 December 2018
SN:019/18 Safety Notice Amber Oxygen Cylinders with Integrated Valve Regulator29 November 2018
SN:018/18 Safety Notice Amber Newborn Self-Inflating Bag (SIB) resuscitators27 November 2018
SN:017/18 Safety Notice Amber Printing the correct ECG for patients Correction to Para 2: QLD Health27 November 2018
SN:015/18 Safety Notice Amber Parietex composite parastomal mesh hazard alert and recall9 November 2018
SI:003/18 Safety Information Green Candida auris infection considerations for the transfer or repatriation of an overseas patient to a NSW hospital7 September 2018
SN:012/18 Safety Notice Amber Rupture of membranes testing in maternity settings20 August 2018
SN:009/18 Safety Notice Amber Intragastric Balloon Systems6 August 2018
SN:008/18 Safety Notice Amber Return of Patients’ Own Medications25 July 2018
SI:001/18 Safety Information Green ABO Compatibility for Blood Products in an Emergency19 June 2018
SN:005/18 Safety Notice Amber Peri-operative risk of SGLT2 inhibitor–associated ketoacidosis15 March 2018
SN:003/18 Safety Notice Amber Complications Associated with Inferior Vena Cava Filters19 February 2018
SA:001/18 Safety Alert Red Vaccine storage and cold chain management9 February 2018
SN:015/17 Safety Notice Amber Transvaginal mesh implants for Pelvic Organ (Vaginal) Prolapse(Supersedes SN:010/17)20 December 2017
SN:011/17 Safety Notice Amber Disposable Ventilator Catheter Mounts Failure29 September 2017
SI:002/17 Safety Information Green Gadolinium-based contrast agents for MRI scans15 August 2017
SA:003/17 Safety Alert Red Infection from contaminated ultrasound gel 12 May 2017
SI:001/17 Safety Information Green Choking Risk in Mental Health Consumers 6 February 2017
SN:001/17 Safety Notice Amber Vaccine cold chain management in NSW Facilities 2 February 2017
SA:002/17 Safety Alert Red Insufflator Gas Connectors 12 January 2017
SN:010/16 Safety Notice Amber Medical gas cylinders(Supersedes Safety Notice 004/10 issued on 22 April 2010) 10 October 2016
SI:002/16 Safety Information Green Switching between Extended Release (XR) vs Immediate Release (IR) Formulations25 August 2016
SN:004/16 Safety Notice Amber Assessment and management of risk of absconding from declared mental health inpatient units 22 June 2016
SN:003/16 Safety Notice Amber Use of Prone Restraint and Parenteral Medication in Healthcare Settings 14 July 2016
SI:001/16 Safety Information Green Increase in Cases of Invasive Meningococcal Disease 19 February 2016
SI:001/15 Safety Information Green E – Cigarettes, Oxygen Therapy, Burns and Fire Risk 20 January 2015
SI:001/14 Green Safety Information Correct Usage of Fume/Vapour Soaking Stations 24 January 2014
SN:001/14 Safety Notice Amber Use of Impregnated Chemical Disinfectant Wipe Systems for Reusable Medical Devices 24 January 2014
SI:002/12 Safety Information Green Measles Outbreak 31 August 2012
SI:001/12 Safety Information Green Antenatal magnesium sulphate infusion prior to preterm birth for neuroprotection of the foetus infant and child4 May 2012
SA:008/11 Safety Alert Red Pneumocystis jirovecii Pneumonia (PJP) in transplant patients19 December 2011
SN:015/11 Safety Notice Amber Bathing of Newborn Babies and Infection Prevention 22 November 2011
SN:017/10 Safety Notice Amber Group A Streptococcal Maternal Sepsis 24 December 2010
SN:010/10 Safety Notice Amber Correct identification of medication and solutions for epidural anaesthesia and analgesia 25 August 2010
SN:006/10 Safety Notice Amber Pathology Testing - Caesarean Section Operations 16 June 2010
SN:022/09 Safety Notice Amber Safe use of Midazolam 18 December 2009
SN:016/09 Safety Notice Amber Safe Instrumental Birth 28 July 2009
SN:014/09 Safety Notice Amber Retained or Broken Orthopaedic Surgical Equipment in Patients 9 July 2009
SA:003/09 Safety Alert Red Draeger Medical Babylog 8000 Plus Neonatal Ventilator26 June 2009
SN:011/09 Safety Notice Amber Allopurinol and Azathioprine 7 May 2009
SN:006/09 Safety Notice Amber Wrong Route Errors with Oral Medication 25 March 2009
SA:001/09 Safety Alert Red PEEP Valve, Expiration Diverter Assembly 13 February 2009
SI:001/09 Safety Information Green Drager Oxylog 2000 Transport Ventilator8 January 2009
SN:004/07 Safety Notice Amber Shower Curtain and Curtain Tracks in Mental Health Facilities 28 March 2007
SN:003/07 Safety Notice Amber Creutzfeldt - Jacob Disease (CJD) Transmission During High Risk Surgical Procedures(“dorsal route ganglia” amended to read "dorsal root ganglia" - updated 20 March 07)19 March 2007
(revised 20 March 2007)
SN:003/06 Safety Notice Amber Peiron Stent fracture in renal arteriesOctober 2006

Current as at: Monday 23 May 2022